Green Thumb Industries (GTBIF) Accumulated Expenses (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Accumulated Expenses came in at $75.3 million in Q1 2026, down 1.88% YoY from $76.7 million in Q1 2025, and down 14.95% on a QoQ basis from $88.5 million in Q4 2025.
Green Thumb Industries (GTBIF) Accumulated Expenses (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Accumulated Expenses data on file, last reported at $75.3 million in Q1 2026.
- Quarterly Accumulated Expenses fell 1.88% year-over-year to $75.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.3 million (down 1.88% YoY) and the FY2025 annual result came in at $88.5 million, up 2.71% from the prior year.
- Accumulated Expenses retreated to $75.3 million in Q1 2026, from $88.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $116.9 million in Q2 2023 to a low of $59.6 million in Q4 2023.
- A 5-year average of $80.2 million and a median of $76.7 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses soared 54.25% — and 2024, when it plunged 46.29%.
- Tracing GTBIF's Accumulated Expenses over 5 years: stood at $87.0 million in 2022, then tumbled by 31.53% to $59.6 million in 2023, then soared by 44.68% to $86.2 million in 2024, then grew by 2.71% to $88.5 million in 2025, then retreated by 14.95% to $75.3 million in 2026.
- The last three Accumulated Expenses figures came in at $75.3 million (Q1 2026), $88.5 million (Q4 2025), and $82.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.76 Mn |
| Mar 31, 2026 | 75.27 Mn |
| Dec 31, 2025 | 88.50 Mn |
| Sep 30, 2025 | 82.76 Mn |
| Jun 30, 2025 | 73.65 Mn |
| Mar 31, 2025 | 76.71 Mn |
| Dec 31, 2024 | 86.16 Mn |
| Sep 30, 2024 | 75.58 Mn |
| Jun 30, 2024 | 62.78 Mn |
| Mar 31, 2024 | 68.24 Mn |
| Dec 31, 2023 | 59.55 Mn |
| Sep 30, 2023 | 86.47 Mn |
| Jun 30, 2023 | 116.89 Mn |
| Mar 31, 2023 | 99.92 Mn |
| Dec 31, 2022 | 86.97 Mn |
| Sep 30, 2022 | 71.52 Mn |
| Jun 30, 2022 | 75.78 Mn |
| Mar 31, 2022 | 77.21 Mn |
| Dec 31, 2021 | 84.72 Mn |
| Sep 30, 2021 | 78.70 Mn |